Literature DB >> 17957408

11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas.

Tarun Singhal1, Tanjore K Narayanan, Viney Jain, Jogeshwar Mukherjee, Joseph Mantil.   

Abstract

Positron emission tomography (PET) using L-[methyl-(11)C]-methionine (MET) is the most popular amino acid imaging modality in oncology, although its use is restricted to PET centers with an in-house cyclotron facility. This review focuses on the role of MET-PET in imaging of cerebral gliomas. The biological background of tumor imaging with methionine is discussed with particular emphasis on cellular amino acid transport, amino acid utilization in brain, normal metabolism of methionine, and its alterations in cancer. The role of MET-PET in clinical management of cerebral gliomas in initial diagnosis, differentiation of tumor recurrence from radiation injury, grading, prognostication, tumor-extent delineation, biopsy planning, surgical resection and radiotherapy planning, and assessment of response to therapy is also reviewed in detail.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17957408     DOI： 10.1007/s11307-007-0115-2

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN： 1536-1632            Impact factor:   3.488


  158 in total

1.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

2.  Effect on in vitro methylation on the chromatographic and coding properties of methyl-deficient leucine transfer RNA.

Authors:  J D Capra; A Peterkofsky
Journal:  J Mol Biol       Date:  1968-05-14       Impact factor: 5.469

3.  The 4F2hc surface antigen is necessary for expression of system L-like neutral amino acid-transport activity in C6-BU-1 rat glioma cells: evidence from expression studies in Xenopus laevis oocytes.

Authors:  S Bröer; A Bröer; B Hamprecht
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

4.  High L-methyl-[11C]methionine uptake in brain abscess: a PET study.

Authors:  K Ishii; T Ogawa; J Hatazawa; I Kanno; A Inugami; H Fujita; E Shimosegawa; M Murakami; T Okudera; K Uemura
Journal:  J Comput Assist Tomogr       Date:  1993 Jul-Aug       Impact factor: 1.826

5.  123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.

Authors:  Michail Plotkin; Julia Eisenacher; Harald Bruhn; Reinhard Wurm; Roger Michel; Florian Stockhammer; Annelie Feussner; Oliver Dudeck; Peter Wust; Roland Felix; Holger Amthauer
Journal:  J Neurooncol       Date:  2004-10       Impact factor: 4.130

6.  Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology.

Authors:  Lutz W Kracht; Hrvoje Miletic; Susanne Busch; Andreas H Jacobs; Jurgen Voges; Moritz Hoevels; Johannes C Klein; Karl Herholz; Wolf-D Heiss
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

7.  Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies.

Authors:  Benoit Pirotte; Serge Goldman; Nicolas Massager; Philippe David; David Wikler; Maurice Lipszyc; Isabelle Salmon; Jacques Brotchi; Marc Levivier
Journal:  J Neurosurg       Date:  2004-09       Impact factor: 5.115

8.  Synthesis of L- and D-[methyl-11C]methionine.

Authors:  B Långström; G Antoni; P Gullberg; C Halldin; P Malmborg; K Någren; A Rimland; H Svärd
Journal:  J Nucl Med       Date:  1987-06       Impact factor: 10.057

9.  Positron emission tomography and computed tomography in differential diagnosis between recurrent or residual glioma and treatment-induced brain lesions.

Authors:  A Lilja; H Lundqvist; Y Olsson; B Spännare; P Gullberg; B Långström
Journal:  Acta Radiol       Date:  1989 Mar-Apr       Impact factor: 1.990

10.  Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.

Authors:  Benoit Pirotte; Serge Goldman; Nicolas Massager; Philippe David; David Wikler; Arlette Vandesteene; Isabelle Salmon; Jacques Brotchi; Marc Levivier
Journal:  J Nucl Med       Date:  2004-08       Impact factor: 10.057
View more
  62 in total

1.  A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.

Authors:  Makoto Ideguchi; Takafumi Nishizaki; Norio Ikeda; Tomomi Okamura; Yasue Tanaka; Natsumi Fujii; Machiko Ohno; Taichi Shimabukuro; Tokuhiro Kimura; Eiji Ikeda; Kazuyoshi Suga
Journal:  J Neurooncol       Date:  2018-03-07       Impact factor: 4.130

2.  The roles of 11C-acetate PET/CT in predicting tumor differentiation and survival in patients with cerebral glioma.

Authors:  Soyoung Kim; Dongwoo Kim; Se Hoon Kim; Mi-Ae Park; Jong Hee Chang; Mijin Yun
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-06       Impact factor: 9.236

3.  PET imaging for Treatment Response in Cancer.

Authors:  Janet F Eary
Journal:  PET Clin       Date:  2008-01-01

Review 4.  Nuclear imaging of molecular processes in cancer.

Authors:  Rafael Torres Martin de Rosales; Erik Arstad; Philip J Blower
Journal:  Target Oncol       Date:  2009-09-25       Impact factor: 4.493

Review 5.  Metabolic positron emission tomography imaging in cancer detection and therapy response.

Authors:  Aizhi Zhu; Daniel Lee; Hyunsuk Shim
Journal:  Semin Oncol       Date:  2011-02       Impact factor: 4.929

6.  Increased L-[1-11 C] leucine uptake in the leptomeningeal angioma of sturge-weber syndrome: a PET study.

Authors:  Bálint Alkonyi; Harry T Chugani; Otto Muzik; Diane C Chugani; Senthil K Sundaram; William J Kupsky; Carlos E Batista; Csaba Juhász
Journal:  J Neuroimaging       Date:  2011-01-11       Impact factor: 2.486

Review 7.  Fluorescence-guided surgery with aminolevulinic acid for low-grade gliomas.

Authors:  Benjamin K Hendricks; Nader Sanai; Walter Stummer
Journal:  J Neurooncol       Date:  2018-10-26       Impact factor: 4.130

Review 8.  Radiotracers for positron emission tomography imaging.

Authors:  Nic Gillings
Journal:  MAGMA       Date:  2012-12-16       Impact factor: 2.310

9.  PET radiopharmaceuticals for probing enzymes in the brain.

Authors:  Jason P Holland; Paul Cumming; Neil Vasdev
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-04-09

10.  Breast cancer cells imaging by targeting methionine transporters with gadolinium-based nanoprobe.

Authors:  Bita Mehravi; Mehdi Shafiee Ardestani; Maryam Damercheli; Haleh Soltanghoraee; Negar Ghanaldarlaki; Ali M Alizadeh; Mohammad A Oghabian; Maryam Shahzad Shirazi; Shabnam Mahernia; Massoud Amanlou
Journal:  Mol Imaging Biol       Date:  2014-08       Impact factor: 3.488
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.